title: Intralesional triamcinolone acetonide in alopecia areata amongst 62 Saudi Arabs.
abstract: Evaluation of 62 Saudi Arabs with alopecia areata on monthly intralesional injection of triamcinolone acetonide, showed complete regrowth in 40 (63%) patients at 4 months. Regrowth was likely in young adults with few lesions (less than 5 patches), lesions of short durations (less than 1 month) patches less than 3 cm in diameter. Regrowth was poor when associated with atopy (2 patients) and mongolism (1 patient). Side effects of treatment were minimal and the drug was well tolerated.
authors: Arar Central Hospital, Kingdom of Saudi Arabia.
authors: E P
authors: EP
authors: Kubeyinje
mesh_terms: D000293:Adolescent; D000328:Adult; D000506:Alopecia Areata / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D002648:Child; D003876:Dermatitis, Atopic / Q000150:complications; D004314:Down Syndrome / Q000150:complications; D004334:Drug Administration Schedule; D005260:Female; D006197:Hair / Q000187:drug effects / Q000254:growth & development; D006801:Humans; D015552:Injections, Intralesional; D008297:Male; D008875:Middle Aged; D012529:Saudi Arabia; D014222:Triamcinolone Acetonide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D014222:Triamcinolone Acetonide